Implantable Drug Delivery Systems (IDDS) After Failure of Comprehensive Medical Management (CMM) Can Palliate Symptoms in the Most Refractory Cancer Pain Patients
Author:
Affiliation:
1. Thomas Palliative Care Unit, Virginia Commonwealth University, Richmond, Virginia.
Publisher
Mary Ann Liebert Inc
Subject
Anesthesiology and Pain Medicine,General Medicine,General Nursing
Link
http://www.liebertpub.com/doi/pdf/10.1089/jpm.2005.8.736
Reference10 articles.
1. Randomized Clinical Trial of an Implantable Drug Delivery System Compared With Comprehensive Medical Management for Refractory Cancer Pain: Impact on Pain, Drug-Related Toxicity, and Survival
2. What Is the Evidence for Implantable Drug Delivery Systems for Refractory Cancer Pain?
3. When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function
4. Symptoms during cancer pain treatment following WHO-guidelines: a longitudinal follow-up study of symptom prevalence, severity and etiology
5. Implementing Guidelines for Cancer Pain Management: Results of a Randomized Controlled Clinical Trial
Cited by 48 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Implanted intrathecal drug delivery systems may be associated with improved survival in patients with cancer;British Journal of Pain;2023-10-16
2. More time in a community setting: A service evaluation of the impact of intrathecal drug delivery systems on place of care of patients with cancer pain;Palliative Medicine;2023-08-26
3. Minimally invasive interventional therapy for pain;Journal of Interventional Medicine;2023-05
4. Refractory Cancer Pain and Intrathecal Therapy: Critical Review of a Systematic Review;Pain and Therapy;2023-04-13
5. Effectiveness and Safety of Intrathecal Drug Delivery Systems for the Management of Cancer Pain: A Systematic Review and Meta-Analysis;Neuromodulation: Technology at the Neural Interface;2022-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3